282 related articles for article (PubMed ID: 28507024)
1. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
[TBL] [Abstract][Full Text] [Related]
2. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
3. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
Rowley J; Monie A; Hung CF; Wu TC
J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
[TBL] [Abstract][Full Text] [Related]
5. Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
Luque Y; Cathelin D; Vandermeersch S; Xu X; Sohier J; Placier S; Xu-Dubois YC; Louis K; Hertig A; Bories JC; Vasseur F; Campagne F; Di Santo JP; Vosshenrich C; Rondeau E; Mesnard L
Kidney Int; 2017 May; 91(5):1146-1158. PubMed ID: 28111009
[TBL] [Abstract][Full Text] [Related]
6. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
[TBL] [Abstract][Full Text] [Related]
7. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
8. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
[TBL] [Abstract][Full Text] [Related]
9. IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells.
Yu P; Bamford RN; Waldmann TA
Eur J Immunol; 2014 Nov; 44(11):3330-41. PubMed ID: 25142300
[TBL] [Abstract][Full Text] [Related]
10. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
Van Belle TL; Dooms H; Boonefaes T; Wei XQ; Leclercq G; Grooten J
PLoS One; 2012; 7(9):e45299. PubMed ID: 23028916
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Receptor-Associated Protein Complex Assembly in Interleukin (IL)-2- and IL-15-Activated T-Cell Lines.
Osinalde N; Sanchez-Quiles V; Akimov V; Aloria K; Arizmendi JM; Blagoev B; Kratchmarova I
J Proteome Res; 2017 Jan; 16(1):106-121. PubMed ID: 27463037
[TBL] [Abstract][Full Text] [Related]
12. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15.
Ring AM; Lin JX; Feng D; Mitra S; Rickert M; Bowman GR; Pande VS; Li P; Moraga I; Spolski R; Ozkan E; Leonard WJ; Garcia KC
Nat Immunol; 2012 Dec; 13(12):1187-95. PubMed ID: 23104097
[TBL] [Abstract][Full Text] [Related]
14. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
[TBL] [Abstract][Full Text] [Related]
15. The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15.
Ramsey C; Rubinstein MP; Kim DM; Cho JH; Sprent J; Surh CD
J Immunol; 2008 Apr; 180(8):5320-6. PubMed ID: 18390713
[TBL] [Abstract][Full Text] [Related]
16. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation.
Ota N; Takase M; Uchiyama H; Olsen SK; Kanagawa O
J Immunol; 2010 Nov; 185(10):6041-8. PubMed ID: 20926799
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-15 in gene therapy of cancer.
Ochoa MC; Mazzolini G; Hervas-Stubbs S; de Sanmamed MF; Berraondo P; Melero I
Curr Gene Ther; 2013 Feb; 13(1):15-30. PubMed ID: 23157547
[TBL] [Abstract][Full Text] [Related]
18. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
19. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
Soper DM; Kasprowicz DJ; Ziegler SF
Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
[TBL] [Abstract][Full Text] [Related]
20. T-bet-mediated differentiation of the activated CD8+ T cell.
Yeo CJ; Fearon DT
Eur J Immunol; 2011 Jan; 41(1):60-6. PubMed ID: 21182077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
